BR112012007179B8 - composto inibidor da di-hidro-orotato desidrogenase, e, formulação farmacêutica - Google Patents
composto inibidor da di-hidro-orotato desidrogenase, e, formulação farmacêuticaInfo
- Publication number
- BR112012007179B8 BR112012007179B8 BR112012007179A BR112012007179A BR112012007179B8 BR 112012007179 B8 BR112012007179 B8 BR 112012007179B8 BR 112012007179 A BR112012007179 A BR 112012007179A BR 112012007179 A BR112012007179 A BR 112012007179A BR 112012007179 B8 BR112012007179 B8 BR 112012007179B8
- Authority
- BR
- Brazil
- Prior art keywords
- dihydro
- pharmaceutical formulation
- compound
- inhibitor compound
- dehydrogenase inhibitor
- Prior art date
Links
- 150000001875 compounds Chemical class 0.000 title abstract 5
- 239000008194 pharmaceutical composition Substances 0.000 title abstract 3
- 229940083266 Dihydroorotate dehydrogenase inhibitor Drugs 0.000 title abstract 2
- 239000003363 dihydroorotate dehydrogenase inhibitor Substances 0.000 title abstract 2
- 108010052167 Dihydroorotate Dehydrogenase Proteins 0.000 abstract 1
- 102100032823 Dihydroorotate dehydrogenase (quinone), mitochondrial Human genes 0.000 abstract 1
- 101100085783 Drosophila melanogaster Dhod gene Proteins 0.000 abstract 1
- 102000004190 Enzymes Human genes 0.000 abstract 1
- 108090000790 Enzymes Proteins 0.000 abstract 1
- 239000003814 drug Substances 0.000 abstract 1
- 239000003112 inhibitor Substances 0.000 abstract 1
- 201000004792 malaria Diseases 0.000 abstract 1
- 230000003071 parasitic effect Effects 0.000 abstract 1
- 150000003839 salts Chemical class 0.000 abstract 1
- 239000012453 solvate Substances 0.000 abstract 1
- 229940124597 therapeutic agent Drugs 0.000 abstract 1
- 229940124598 therapeutic candidate Drugs 0.000 abstract 1
- 150000008523 triazolopyridines Chemical class 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
- C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
- C07D487/04—Ortho-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P33/00—Antiparasitic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P33/00—Antiparasitic agents
- A61P33/02—Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P33/00—Antiparasitic agents
- A61P33/02—Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
- A61P33/06—Antimalarials
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Landscapes
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Tropical Medicine & Parasitology (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US24686309P | 2009-09-29 | 2009-09-29 | |
US61/246863 | 2009-09-29 | ||
PCT/US2010/050532 WO2011041304A2 (en) | 2009-09-29 | 2010-09-28 | Antimalarial agents that are inhibitors of dihydroorotate dehydrogenase |
Publications (4)
Publication Number | Publication Date |
---|---|
BR112012007179A2 BR112012007179A2 (pt) | 2017-07-25 |
BR112012007179A8 BR112012007179A8 (pt) | 2018-01-23 |
BR112012007179B1 BR112012007179B1 (pt) | 2020-12-01 |
BR112012007179B8 true BR112012007179B8 (pt) | 2021-05-25 |
Family
ID=43826848
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
BR112012007179A BR112012007179B8 (pt) | 2009-09-29 | 2010-09-28 | composto inibidor da di-hidro-orotato desidrogenase, e, formulação farmacêutica |
Country Status (15)
Families Citing this family (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2015095477A1 (en) * | 2013-12-19 | 2015-06-25 | Irm Llc | [1,2,4]triazolo[1,5-a]pyrimidine derivatives as protozoan proteasome inhibitors for the treatment of parasitic diseases such as leishmaniasis |
EP3072894A1 (en) * | 2015-03-26 | 2016-09-28 | Board Of Regents Of the University Of Texas System | New substituted triazolopyrimidines as anti-malarial agents |
EP3254679A1 (de) | 2016-06-09 | 2017-12-13 | Christian-Albrechts-Universität zu Kiel | Wirkstoffe gegen protozoen und bakterien |
EP3525786A4 (en) * | 2016-10-12 | 2020-03-18 | Merck Sharp & Dohme Corp. | KDM5 INHIBITORS |
US11690847B2 (en) | 2016-11-30 | 2023-07-04 | Case Western Reserve University | Combinations of 15-PGDH inhibitors with corticosteroids and/or TNF inhibitors and uses thereof |
JP2020514323A (ja) * | 2017-02-06 | 2020-05-21 | ケース ウエスタン リザーブ ユニバーシティ | 短鎖デヒドロゲナーゼ活性を調節する組成物と方法 |
US11426420B2 (en) | 2017-04-07 | 2022-08-30 | Case Western Reserve University | Inhibitors of short-chain dehydrogenase activity for treating coronary disorders |
CR20250174A (es) | 2018-11-21 | 2025-06-10 | Rodeo Therapeutics Corp | COMPOSICIONES Y MÉTODOS PARA MODULAR LA ACTIVIDAD DE DESHIDROGENASAS DE CADENA CORTA (Divisional 2021-0328) |
EP3842100A1 (en) * | 2019-12-24 | 2021-06-30 | The Board Of Regents Of The University Of Texas System | Anti-malarial agents |
Family Cites Families (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5478825A (en) | 1991-02-22 | 1995-12-26 | Egis Gyogyszergyar | 5-(substituted amino)-1,2,4-triazolo (1,5-A) pyrimidine derivatives |
HU208693B (en) * | 1991-02-22 | 1993-12-28 | Egyt Gyogyszervegyeszeti Gyar | Process for producing 1,2,4-triazolo (1,5-a) pyrimidinis derivatives and their carbicycli-tetrahydro-thiofurane-tetrahydrothiopyrane-, or tetrahydropyridine- condensated derivatives or medical preparatives containing them |
US8490825B2 (en) | 1999-12-08 | 2013-07-23 | Metal Container Corporation | Can lid closure and method of joining a can lid closure to a can body |
CZ294535B6 (cs) * | 2001-08-02 | 2005-01-12 | Ústav Experimentální Botaniky Avčr | Heterocyklické sloučeniny na bázi N6-substituovaného adeninu, způsoby jejich přípravy, jejich použití pro přípravu léčiv, kosmetických přípravků a růstových regulátorů, farmaceutické přípravky, kosmetické přípravky a růstové regulátory tyto sloučeniny obsahující |
US20080027079A1 (en) * | 2006-06-22 | 2008-01-31 | Board Of Regents, University Of Texas System | Dihydroorotate dehydrogenase inhibitors with selective anti-malarial activity |
CN101622001A (zh) * | 2007-01-26 | 2010-01-06 | Irm责任有限公司 | 作为激酶抑制剂用于治疗疟原虫相关疾病的嘌呤化合物和组合物 |
WO2009082691A1 (en) | 2007-12-21 | 2009-07-02 | Board Of Regents, University Of Texas System | Dihydroorotate dehydrogenase inhibitors with selective anti-malarial activity |
-
2010
- 2010-09-28 ME MEP-2015-8A patent/ME02020B/me unknown
- 2010-09-28 CA CA2775354A patent/CA2775354C/en not_active Expired - Fee Related
- 2010-09-28 DK DK10821105.3T patent/DK2483274T3/en active
- 2010-09-28 PT PT108211053T patent/PT2483274E/pt unknown
- 2010-09-28 EP EP10821105.3A patent/EP2483274B1/en active Active
- 2010-09-28 JP JP2012532236A patent/JP5818266B2/ja not_active Expired - Fee Related
- 2010-09-28 ES ES10821105.3T patent/ES2527835T3/es active Active
- 2010-09-28 WO PCT/US2010/050532 patent/WO2011041304A2/en active Application Filing
- 2010-09-28 BR BR112012007179A patent/BR112012007179B8/pt not_active IP Right Cessation
- 2010-09-28 PL PL10821105T patent/PL2483274T3/pl unknown
- 2010-09-28 HR HRP20150066AT patent/HRP20150066T1/hr unknown
- 2010-09-28 US US13/499,031 patent/US9238653B2/en not_active Expired - Fee Related
- 2010-09-28 CN CN201080043385.XA patent/CN102741255B/zh not_active Expired - Fee Related
- 2010-09-28 SI SI201030853T patent/SI2483274T1/sl unknown
-
2015
- 2015-03-18 SM SM201500071T patent/SMT201500071B/xx unknown
Also Published As
Publication number | Publication date |
---|---|
WO2011041304A3 (en) | 2011-08-04 |
HRP20150066T1 (hr) | 2015-02-27 |
EP2483274A2 (en) | 2012-08-08 |
ES2527835T3 (es) | 2015-01-30 |
CA2775354A1 (en) | 2011-04-07 |
BR112012007179A2 (pt) | 2017-07-25 |
HK1174639A1 (en) | 2013-06-14 |
CA2775354C (en) | 2019-01-15 |
CN102741255A (zh) | 2012-10-17 |
US9238653B2 (en) | 2016-01-19 |
JP5818266B2 (ja) | 2015-11-18 |
JP2013506004A (ja) | 2013-02-21 |
SI2483274T1 (sl) | 2015-02-27 |
PT2483274E (pt) | 2015-02-04 |
SMT201500071B (it) | 2015-05-05 |
ME02020B (me) | 2015-05-20 |
PL2483274T3 (pl) | 2015-04-30 |
EP2483274B1 (en) | 2014-10-29 |
EP2483274A4 (en) | 2013-03-06 |
BR112012007179A8 (pt) | 2018-01-23 |
CN102741255B (zh) | 2015-10-07 |
US20120302586A1 (en) | 2012-11-29 |
DK2483274T3 (en) | 2015-01-19 |
WO2011041304A2 (en) | 2011-04-07 |
BR112012007179B1 (pt) | 2020-12-01 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
BR112012007179B8 (pt) | composto inibidor da di-hidro-orotato desidrogenase, e, formulação farmacêutica | |
ECSP20027480A (es) | Indolil alquil amino derivados sustituidos como nuevos inhibidores de la histona desacetilasa | |
BR112012023382A2 (pt) | compostos, composições e métodos de uso de imidazopiridina. | |
ECSP067076A (es) | Derivados de pirimidina urea como inhibidores de la quinasa | |
BR112014010407A2 (pt) | compostos de azetidina, composições e seu uso como inibidores de hidrolase de epóxido solúvel | |
EA201200049A1 (ru) | 1,3-дизамещенные производные имидазолидин-2-она в качестве ингибиторов cyp 17 | |
CL2009000316A1 (es) | Compuestos derivados de urea de benzomorfanos y sus sales, inhibidores de la enzima 11-beta-hidroxiesteroide deshidrogenasa; procedimiento de preparacion; composicion farmaceutica; y uso para el tratamiento o prevencion de trastornos metabolicos. | |
SV2011004061A (es) | Aril-piridinas como inhibidores de sintasa de aldosterona | |
ECSP10010419A (es) | Derivados heterocíclicos de urea y métodos de uso de los mismos-211 | |
BRPI1011657A2 (pt) | derivados aminopropiônicos substituídos como inibidores de neprilisina | |
SV2011004077A (es) | Derivados aminobutiricos sustituidos como inhibidores de neprilisina | |
UY33075A (es) | Derivados de ciclohexano y usos de los mismos | |
SMT201300109B (it) | Imidazopiridazincarbonitrili utili come inibitori di chinasi | |
UY32158A (es) | Derivados heterociclicos y metodos de uso de los mismos | |
NO20090628L (no) | Pyridizinon derivativater | |
BR112013011580A2 (pt) | derivados de ácido bisfenil pentanoico substituído por amino como inibidores de nep | |
CL2013000351A1 (es) | Compuestos derivados de 2-(arilamino)-3h-imidazo[4,5-b]piridina-6-carboxamida; inhibidores de la prostaglandina e2 sintasa-1 microsomal (mpges-1) composicion farmaceutica que comprende a uno de los compuestos; y uso de los compuestos en la preparacion de medicamentos para el tratamiento de enfermedades inflamatorias. | |
UY32203A (es) | Amino pirimidinas y su uso en terapia | |
EA201001013A1 (ru) | Бис(сульфониламино)производные для применения в терапии | |
CR11857A (es) | Compuestos pirazolicos 436 | |
PA8658301A1 (es) | Derivados fusionados de pirazol y metodos de tratamiento de trastornos metabolicos con estos | |
GEP20156242B (en) | 2-arylimidazole derivatives as pde10a enzyme inhibitors | |
EA201170680A1 (ru) | Ингибиторы акт и p70 s6-киназы | |
UY30298A1 (es) | Inhibidores de la quinasa c-fms ii | |
EA201270590A1 (ru) | Ингибиторы акт |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
B07D | Technical examination (opinion) related to article 229 of industrial property law [chapter 7.4 patent gazette] | ||
B06F | Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette] | ||
B07E | Notification of approval relating to section 229 industrial property law [chapter 7.5 patent gazette] |
Free format text: NOTIFICACAO DE ANUENCIA RELACIONADA COM O ART 229 DA LPI |
|
B06U | Preliminary requirement: requests with searches performed by other patent offices: procedure suspended [chapter 6.21 patent gazette] | ||
B06A | Patent application procedure suspended [chapter 6.1 patent gazette] | ||
B09A | Decision: intention to grant [chapter 9.1 patent gazette] | ||
B16A | Patent or certificate of addition of invention granted [chapter 16.1 patent gazette] |
Free format text: PRAZO DE VALIDADE: 10 (DEZ) ANOS CONTADOS A PARTIR DE 01/12/2020, OBSERVADAS AS CONDICOES LEGAIS. |
|
B16C | Correction of notification of the grant [chapter 16.3 patent gazette] |
Free format text: PRAZO DE VALIDADE: 20 (VINTE) ANOS CONTADOS A PARTIR DE 28/09/2010 OBSERVADAS AS CONDICOES LEGAIS. PATENTE CONCEDIDA CONFORME ADI 5.529/DF |
|
B21F | Lapse acc. art. 78, item iv - on non-payment of the annual fees in time |
Free format text: REFERENTE A 11A ANUIDADE. |
|
B24J | Lapse because of non-payment of annual fees (definitively: art 78 iv lpi, resolution 113/2013 art. 12) |
Free format text: EM VIRTUDE DA EXTINCAO PUBLICADA NA RPI 2640 DE 10-08-2021 E CONSIDERANDO AUSENCIA DE MANIFESTACAO DENTRO DOS PRAZOS LEGAIS, INFORMO QUE CABE SER MANTIDA A EXTINCAO DA PATENTE E SEUS CERTIFICADOS, CONFORME O DISPOSTO NO ARTIGO 12, DA RESOLUCAO 113/2013. |